<DOC>
	<DOCNO>NCT00414661</DOCNO>
	<brief_summary>The purpose study follow health subject previously enrol study CP-690,550 treatment rheumatoid arthritis . Subjects eligible study complete participation study CP-690,550 .</brief_summary>
	<brief_title>Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550</brief_title>
	<detailed_description>At last visit qualify study , eligible subject give opportunity participate study .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects complete participation Phase 2B Phase 3 study CP690,550 rheumatoid arthritis . Any subject refuse consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Observational non-interventional long-term safety</keyword>
</DOC>